7 results
IDSA Treatment Recommendations for Cryptococcal Meningoencephalitis - Induction, Consolidation and Maintenance Therapy

Table 2. Antifungal Treatment Recommendations
for Cryptococcal ... and Maintenance Therapy ... Recommendations for Cryptococcal ... Recommendations for Cryptococcal ... Recommendations for Cryptococcal
Rare Invasive Yeasts - Species and Antifungal Therapy

Cryptococcus, 
Geotrichum, 
Kodamaea, 
(Pichia)ohmeri, 
Malassezia, 
Pseudozyma, 
Rhodotorula, 
Saccharomyces, 
Saprochaete
and Antifungal Therapy ... Cryptococcus ... Yeasts #Antifungal #Therapy ... #Management #Table ... #Antibiogram #sensitivities
IDSA Treatment Recommendations for Cryptococcal Meningoencephalitis in Human Immunodeficiency Virus Infected Individuals
Induction therapy:
 • AmBd (0.7–1.0
IDSA Treatment Recommendations ... for Cryptococcal ... week) >1 year #Cryptococcal ... Meningoencephalitis #IDSA ... management #meningitis #cryptococcus
Spectrum of activity for systemic antifungal agents
Antifungals: 5FC, flucytosine; AMB, amphotericin B; ANI, anidulafungin; CAS, caspofungin;
fluconazole; ISA ... Aspergillus fumigatus, Cryptococcus ... #Antifungal #antibiogram ... pharmacology #spectrum #coverage
IDSA Treatment Recommendations for Cryptococcal Meningoencephalitis in Transplant Recipients
Induction therapy:
 • liposomal AmB (3–4 mg/kg per
IDSA Treatment Recommendations ... for Cryptococcal ... year B-III #Cryptococcal ... Meningoencephalitis #IDSA ... management #meningitis #cryptococcus
Coverage of common antibiotics used in the hospital

For empiric coverage, first define the type of infection,
Coverage of common ... possible to guide therapy ... preferred & narrowest therapy ... #antibiogram ... pharmacology #table
IDSA Recommendations for Preventing and Treating Cryptococcosis in HIV-AIDS
Treatment for cryptococcosis consists of 3 phases: induction,
IDSA Recommendations ... and maintenance therapy ... Induction Therapy ... Cryptococcosis #Cryptococcus ... #IDSA #Prevention